7 years ago

Synthace Secures $25.6M in Series B Funding

  • Synthace, a London-based provider of a cloud software platform for automating and improving the success rate of biological research and development, closed a $25.6m Series B financing.

      • ProblemTechnology

      "It's really difficult to automate biological research and development. This leads to low success rates and unreliable results."

      Solution

      "Synthace's Antha platform makes it easy to automate biological research and development, so you can get reliable results and increase your success rate. "

      Covered on